Stories

STORIES

Series Embark SERIES EMBARK

Here are some of the many stories about Kyoto-iCAP's relationship with the companies we support.

#29 Developing Functional Enterobacteria Technology to Grow Fish Healthier and Bigger to Support Aquaculture Fisheries

Holo bio Co., Ltd.

#29 Developing Functional Enterobacteria Technology to Grow Fish Healthier and Bigger to Support Aquaculture Fisheries

#28 Development of non-dependent analgesics, a challenge with a completely new mechanism of action!

BTB Therapeutics Co.,Ltd.

#28 Development of non-dependent analgesics, a challenge with a completely new mechanism of action!

#27 Challenge to create a new chemical industry that is friendly to both people and the environment with our unique iron catalyst reaction control technology

TSK Corporation

#27 Challenge to create a new chemical industry that is friendly to both people and the environment with our unique iron catalyst reaction control technology

#26 Elucidating the cause of the disease and developing a new treatment, "ulcerative colitis" as a curable disease.

Link Therapeutics Inc.

#26 Elucidating the cause of the disease and developing a new treatment, "ulcerative colitis" as a curable disease.

#25 Transformation to a Sustainable Industrial Society by Utilizing "Biodiversity"! -Support for new business development to maximize ecosystem functions

Sunlit Seedlings Ltd.

#25 Transformation to a Sustainable Industrial Society by Utilizing "Biodiversity"! -Support for new business development to maximize ecosystem functions

#24 Trying to develop a new SAS treatment device to reduce patient burden

MaRI Co., Ltd.

#24 Trying to develop a new SAS treatment device to reduce patient burden

#23 Providing new value to corporate legal affairs through the use of AI technology, pioneering legal tech

LegalOn Technologies, Inc.

#23 Providing new value to corporate legal affairs through the use of AI technology, pioneering legal tech

#22 iPS Cells for Clinical Applications, Addressing Unmet Needs in Cellular Medicine

Orizuru Therapeutics Inc.

#22 iPS Cells for Clinical Applications, Addressing Unmet Needs in Cellular Medicine

#21 Challenging to Create Innovative Drugs for Targets Considered Difficult to Discover

FIMECS, Inc.

#21 Challenging to Create Innovative Drugs for Targets Considered Difficult to Discover

#20 Pursuing the potential of algae and building an algae development platform

Algal Bio Co., Ltd.

#20 Pursuing the potential of algae and building an algae development platform

#19 Safe and easy, clear imaging of microvessels, innovative technology for medical contribution

Luxonus Inc.

#19 Safe and easy, clear imaging of microvessels, innovative technology for medical contribution

#18 Revolutionizing Dental Treatment with a Dream "Teething Pill"

Toregem BioPharma Co., Ltd.

#18 Revolutionizing Dental Treatment with a Dream "Teething Pill"

Contact UsCONTACT

Please feel free to contact us if you have any questions or concerns.

Inquiry Form